dic(7;9) with loss of Tp53 gene in acute lymphoblastic leukemia

dic(7;9) with loss of Tp53 gene in acute lymphoblastic leukemia

Bibliographic Details
Main Authors:	Anurag Gupta, Krishna G Reddy, Manu Goyal, Pankaj Karwa, Divya G Swarupa, Mukkanteeswara Rao Kasaragadda
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Indian Journal of Pathology and Microbiology
Online Access:	http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2016;volume=59;issue=4;spage=571;epage=573;aulast=Gupta

Similar Items

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD
by: Ali Sakhdari, et al.
Published: (2020-02-01)

WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia
by: Fulvio Bordin, et al.
Published: (2018-02-01)

Constitutively active CaMKII Drives B lineage acute lymphoblastic leukemia/lymphoma in tp53 mutant zebrafish.
by: Sarah C Rothschild, et al.
Published: (2023-12-01)

TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
by: Ugo Testa, et al.
Published: (2023-06-01)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
by: Melania Tesio
Published: (2023-02-01)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia
by: Katharina T. Prochazka, et al.
Published: (2019-03-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)

Tp53 Genetic Mutations in Chronic Lymphocytic Leukemia Patients in Iraq
by: Kareem Abed Mobashr, et al.
Published: (2024-09-01)

Recruiting TP53 to target chronic myeloid leukemia stem cells
by: Steven Grant
Published: (2020-05-01)

Prognostic and therapeutic implications of TP53 expression in chronic myelomonocytic leukemia
by: Yu-Hung Wang, et al.
Published: (2024-07-01)

Charting a path through resistance: histone deacetylase inhibitors for <i>TP53</i>-mutated B-cell acute lymphoblastic leukemia
by: Eitan Kugler
Published: (2024-02-01)

TP53 mutations are frequent in adult acute lymphoblastic leukemia cases negative for recurrent fusion genes and correlate with poor response to induction therapy
by: Sabina Chiaretti, et al.
Published: (2013-05-01)

What have we learned about TP53-mutated acute myeloid leukemia?
by: Moazzam Shahzad, et al.
Published: (2024-11-01)

Case report: TP53 c.848G>A germline mutation as a possible screening target at initial diagnosis for acute lymphoblastic leukemia
by: Fang Hua, et al.
Published: (2024-12-01)

NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia
by: Jana Hof, et al.
Published: (2017-07-01)

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
by: Lennart Lenk, et al.
Published: (2022-08-01)

Therapeutic targeting of mutated p53 in acute lymphoblastic leukemia
by: Frank N. van Leeuwen
Published: (2020-01-01)

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival
by: Silvia Salmoiraghi, et al.
Published: (2016-06-01)

Treatment for a B-cell acute lymphoblastic leukemia patient carrying a rare TP53 c.C275T mutation: A case report
by: Runan Wang, et al.
Published: (2023-01-01)

S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.
by: Diego A Pereira-Martins, et al.
Published: (2023-08-01)

TP53 GENE EXPRESSION IS INCREASED AND CORRELATES WITH RHOC IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: BA Rodrigues, et al.
Published: (2024-10-01)

The TP53 Pro72Arg SNP in de novo acute myeloid leukemia
by: Eduard Schulz, et al.
Published: (2017-05-01)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
by: Elias Campo, et al.
Published: (2018-12-01)

<i>TP53</i> Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
by: Federico Zingarelli, et al.
Published: (2022-11-01)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
by: Miguel Quijada‐Álamo, et al.
Published: (2021-02-01)

Cytoplasmic TP53INP2 acts as an apoptosis partner in TRAIL treatment: the synergistic effect of TRAIL with venetoclax in TP53INP2-positive acute myeloid leukemia
by: Jun Ren, et al.
Published: (2024-06-01)

TP53 variants underlying pediatric low‐hypodiploidy B‐cell acute lymphoblastic leukemia demonstrate diverse origins and may persist as a hematopoietic clone in remission
by: Albert Itov, et al.
Published: (2024-10-01)

TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia
by: Stefanie V. Junk, et al.
Published: (2019-09-01)

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia
by: Salih Demir, et al.
Published: (2020-01-01)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
by: Daver, NG, et al.
Published: (2022)

Therapeutic targeting of TP53 nonsense mutations in cancer
by: Charlotte Strandgren, et al.
Published: (2024-05-01)

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
by: Marianna B. Ruzinova, et al.
Published: (2019-08-01)

Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
by: Matheus F. Bezerra, et al.
Published: (2017-02-01)

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
by: Gelan Zhu, et al.
Published: (2024-12-01)

TP53 Mutations and Clinical Outcome in Chronic Lymphocytic Leukemia: Is a Threshold Still Needed?
by: Riccardo Bomben, et al.
Published: (2023-04-01)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
by: Davidson Zhao, et al.
Published: (2023-03-01)

P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
by: Tamara Kempter, et al.
Published: (2023-08-01)

Convergent TP53 loss and evolvability in cancer
by: Marcela Braga Mansur, et al.
Published: (2023-09-01)

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations
by: Laurence Lodé, et al.
Published: (2018-01-01)

Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment
by: Christian Brieghel, et al.
Published: (2019-04-01)